ziprasidone (Geodon)

DRUG3 trials

Sponsors

Massachusetts General Hospital, Northwestern University, Tufts Medical Center

Conditions

Bipolar DepressionBipolar DisorderDepressionManiaSchizoaffective DisorderSchizophrenia

Phase 2

Safety Study of Ziprasidone (Geodon) for the Depressive Mixed State

CompletedNCT00490542

Tufts Medical CenterBipolar Depression, Bipolar Disorder, Depression

Start: 2006-12-31End: 2009-08-31Updated: 2016-07-29

Phase 3

Estimating and Reducing the Cardiovascular Risk of Patients With Schizophrenia Drugs From Lipid Measures and Ischemic Electrocardiographic Changes

TerminatedNCT00288353

Northwestern UniversityBipolar Disorder, Schizoaffective Disorder, Schizophrenia

Start: 2006-01-31End: 2008-12-31Updated: 2025-10-02

Phase 4

Ziprasidone for the Treatment of Mania in Children and Adolescents With Bipolar Disorder

CompletedNCT00181922

Massachusetts General HospitalBipolar Disorder, Mania

Start: 2002-03-31End: 2004-12-31Target: 20Updated: 2013-10-22

Related Papers

A 6 week randomized double-blind placebo-controlled trial of ziprasidone for the acute depressive mixed state.

2012-04-2446 citations